Actavis Inc.
95 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream" (NCT03954444) | Actavis Inc. | 2019-04-15 |
| Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg (NCT03879837) | Actavis Inc. | 2019-03-25 |
| Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma (NCT03756883) | Actavis Inc. | 2018-12-03 |
| Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension (NCT03499873) | Actavis Inc. | 2018-03-28 |
| Clinical Endpoint Study of Ivermectin 0.5% Lotion (NCT03301649) | Actavis Inc. | 2017-10-07 |
Track Actavis Inc. automatically
Every clearance here is in the API, with alerts when new ones post.